Clinical Trial Update: Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms [NA]

View source ↗

Summary

A completed clinical trial evaluating neoadjuvant chemotherapy response using HD PET/CT, serum glycomic markers, and tissue Muc-1 isoforms in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of California, Davis | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2019-11-13